In short. Active skin inflammation, expectations that do not match a gradual course, descent rather than volume, and anyone who cannot accept a change that cannot be undone.
Key points
- A clinician who says no is offering something a practice that agrees to everything cannot: evidence that the assessment is real.
- The most useful outcome of a consultation may be learning that this substance does not reach the concern, and leaving without a course rather than with one.
This site has argued that this substance is a reasonable choice for a specific kind of problem and a specific kind of patient. It follows that there are patients for whom the honest answer is no, and those cases are worth naming plainly rather than leaving to be discovered at an assessment.
When the tissue is not ready
Active infection or inflammation in or near the intended area is a reason to wait, including an active skin condition, a recent illness, dental work or a vaccination that has the immune system occupied. Pregnancy and breastfeeding are reasons to defer an elective treatment. A history of keloid or hypertrophic scarring, or of an autoimmune or granulomatous condition, is a reason for a specific conversation rather than a general reassurance, because the risk that matters with this substance is exactly the one those histories raise.
When the problem is the wrong kind
Anyone whose concern is a defined hollow or fold should be told that a filler answers it with more control and an exit. Anyone whose concern is descent should be told that this material adds support to tissue and does not reposition what has dropped. Anyone whose concern is a feature they would like reshaped should be told that a diffuse injectable is the wrong instrument for an outline. And anyone whose real concern is surface texture, pigment or barrier damage should be treated at the level of the skin, with no irreversibility at all.
The refusal that is worth hearing
A clinician who says no is offering something a practice that agrees to everything cannot: evidence that the assessment is real. The most useful outcome of a consultation may be learning that this substance does not reach the concern, and leaving without a course rather than with one.
When the expectation is the problem
A patient who needs the result visible within a fortnight, who cannot accept a flat stretch of weeks, or who is choosing this material because it sounds stronger than a filler without having settled what happens if the result is uneven, should be sent away to settle those questions first. A course that cannot be dissolved only works as a decision when it is made as one.
Reasons to stop the consultation
- Active inflammation or infection near the intended area, or a pregnancy that has not been discussed.
- A concern that is a defined hollow, a descended area, or a feature the patient wants reshaped.
- An expectation of a result that can be judged within weeks, or undone if it is not wanted.
Being refused is not a judgement about a person or about how they look. It is a statement about the instrument and the problem, and it is the most useful thing an assessment can produce. A patient who leaves with a clear no has avoided a course of sessions, a year of development and a material that could not have been taken back, in an area that never needed it.
Frequently asked questions
Why would a clinic refuse treatment rather than let me decide?
Because two of the reasons for refusal are clinical rather than a matter of preference: active inflammation near the intended area, and a history that raises the risk of a delayed reaction. The others are mismatches of expectation, and a clinician who proceeds in the face of those is arranging a patient who will be unhappy.
If I am refused, does that mean no treatment is available to me?
No. It usually means this treatment is not the right one. A defined hollow or fold is a filler problem, a descended jawline is a surgical or device question, and a skin problem is treated at the level of the skin. A refusal should come with a direction rather than with nothing.
Could I get a second opinion somewhere else?
You can, and it is worth understanding why the first answer was no. Where the reason was clinical it is unlikely to change. Where the reasoning was not explained, another assessment is a reasonable way to hear it properly, and it is not a reason to shop for a different answer to the same question.
Risks & Limitations
- Irreversibility: there is no dissolving agent for this substance. A lump, an asymmetry or an over-correction is managed over time, with injected treatment, or occasionally by removal, and never switched off.
- Nodules and granulomas — firm lumps or an inflammatory reaction that can appear weeks or months after treatment and may need assessment and treatment rather than simply resolving.
- Unevenness or over-correction. This substance is placed in an area that cannot be dissolved, so over-treatment is harder to correct than under-treatment.
- Firmness under the skin in the first weeks, which is expected and usually settles, but does not always.
- Infection or inflammation at an injection site, which needs prompt assessment rather than waiting.
- Bruising, swelling, tenderness and occasional headache after treatment.
- The volume visible on the day is the carrier rather than the effect. The result develops over months and cannot be judged early, it is not permanent, and the area continues to age.
When to Seek Care
- A firm, growing or painful lump at or near an injection site, appearing weeks or months after treatment — this needs assessment even when it is not painful.
- Redness, warmth, swelling or pus at an injection site, or fever.
- Skin breakdown, blistering, or a dusky or mottled patch over a treated area — seek care immediately.
- Increasing pain, or pain out of proportion to the injection.
- Difficulty breathing, facial swelling or a widespread rash — possible severe reaction; seek emergency care immediately.
References & Further Reading
- American Academy of Dermatology (AAD) — injectable and skin safety information
- American Society of Plastic Surgeons (ASPS) — injectable treatment guidance
- U.S. Food and Drug Administration (FDA) — approved injectable products and safety communications
- National Medical Products Administration (NMPA, China) — approved product status
- Chongqing West District Hospital — Plastic Surgery & Aesthetics Medical Center
This page is patient education, not medical advice, and it does not cite individual studies. Discuss your own case with a qualified clinician. To arrange an assessment at Chongqing West District Hospital, see Contact & Consultation.